Treatment of Chronic Pain with Spinal Cord Stimulation versus Alternative Therapies: Cost-effectiveness Analysis

Kumar, Krishna; Malik, Samaad; Demeria, Denny

doi:10.1097/00006123-200207000-00016

Cited by 219 publications

(179 citation statements)

References 21 publications

Supporting

Mentioning

163

Contrasting

Unclassified

Order By: Relevance

“…This price is the middle value al. 111 suggested that because of the lifespan of the pulse generator battery, these batteries needed replacement after 3.5 to 4.5 years. ABHI's model assumed that the pulse generator needs to be replaced once every 4 years.…”

Section: Neuropathic Pain Model Resultsmentioning

confidence: 99%

“…This assumption was taken from a 5-year analysis of cost for CMM in Canada. 111 Patients that undergo SCS have costs additional to CMM including screening, device implant, device reimplant, etc. (Table 22).…”

Section: Costs Of Health States Monitoring and Treatments In The Modelmentioning

confidence: 99%

“…111 This is taken from a clinical study with a control group of 44 patients where resource consumption data were collected. The costs of CMM were calculated using the following parameters: physician fees, drugs, radiological investigations (e.g.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Simpson

Duenas²,

Holmes³

et al. 2009

Health Technol Assess

190

173

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, from the public and consumer groups and from professional bodies such as royal colleges and NHS trusts. These suggestions are carefully prioritised by panels of independent experts (including NHS service users). The HTA Programme then commissions the research by competitive tender. Second, the HTA Programme provides grants for clinical trials for researchers who identify research questions. These are assessed for importance ...

show abstract

Section: Neuropathic Pain Model Resultsmentioning

confidence: 99%

Section: Costs Of Health States Monitoring and Treatments In The Modelmentioning

confidence: 99%

See 1 more Smart Citation

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Simpson

Duenas²,

Holmes³

et al. 2009

Health Technol Assess

190

173

View full text Add to dashboard Cite

show abstract

“…Serious side effects were not reported. 4)One low quality study examined the cost-effectiveness of SCS (Kumar et al 2002). Patients who were referred for SCS but did not undergo electrode internalisation were used as controls.…”

Section: C11 (B4) Intramuscular Injections Of Botulinum Toxinmentioning

confidence: 99%

Chapter 4 European guidelines for the management of chronic nonspecific low back pain

Airaksinen¹,

Brox²,

Cedraschi³

et al. 2006

Eur Spine J

2,240

1,673

View full text Add to dashboard Cite

“…Mancia et al, 14 in a prospective, randomized, controlled, multicenter study, concluded that the patients with combined SCS and medical management were more costly to the healthcare system, but also had significant functional improvement. Kumar et al 15 16 concluded that ''in selected [complex regional pain syndrome] patients, SCS is a cost-effective option as an adjunct to conventional medical management.'' They also concluded that a rechargeable generator is the most cost-effective option, when the predicted generator longevity is >4 years, despite higher initial cost.…”

Section: Permanent Implantationmentioning

confidence: 99%

Managing Chronic Pain With Spinal Cord Stimulation

Epstein

Palmieri

2012

Mount Sinai J Medicine

View full text Add to dashboard Cite

Since its introduction as a procedure of last resort in a terminally ill patient with intractable cancer‐related pain, spinal cord stimulation has been used to effectively treat chronic pain of varied origins. Spinal cord stimulation is commonly used for control of pain secondary to failed back surgery syndrome and complex regional pain syndrome, as well as pain from angina pectoris, peripheral vascular disease, and other causes. By stimulating one or more electrodes implanted in the posterior epidural space, the patient feels paresthesias in their areas of pain, which reduces the level of pain. Pain is reduced without the side effects associated with analgesic medications. Patients have improved quality of life and improved function, with many returning to work. Spinal cord stimulation has been shown to be cost effective as compared with conservative management alone. There is strong evidence for efficacy and cost effectiveness of spinal cord stimulation in the treatment of pain associated with intractable angina, failed back surgery syndrome, and complex regional pain syndrome. In this article, we review the history and pathophysiology of spinal cord stimulation, and the evidence (or lack thereof) for efficacy in common clinical practice. Mt Sinai J Med 79:123–132, 2012. © 2012 Mount Sinai School of Medicine

show abstract

Treatment of Chronic Pain with Spinal Cord Stimulation versus Alternative Therapies: Cost-effectiveness Analysis

Abstract: SCS is cost-effective in the long term, despite the initial high costs of the implantable devices.

Cited by 219 publications

References 21 publications

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

Chapter 4 European guidelines for the management of chronic nonspecific low back pain

Managing Chronic Pain With Spinal Cord Stimulation

Contact Info

Product

Resources

About